September 18, 2021
2 min watch
Save
VIDEO: Registries play key role in real-world evidence studies
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this video perspective from the virtual Euretina congress, Daniel Barthelmes, MD, PhD, speaks about the key role of registries in investigating treatment outcomes in real-world clinical practice.
The Fight Retinal Blindness Registry has been an invaluable source of data for real-word studies and was the topic of his presentations at the meeting, comparing the outcomes of pharmacotherapies in retinal diseases.
Published by:
Sources/Disclosures
Collapse
Source:
Daniel Barthelmes, MD, PhD
Disclosures:
Barthelmes reports consulting and advising for Alcon, Bayer and Novartis.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.